Coenzyme Q-10

  • SCIENTIFIC NAMES: Mitoquinone; Ubidecarenone; Ubiquinone
  • INDICATIONS: Congestive heart failure, angina, diabetes, hypertension, breast cancer, increasing exercise tolerance, muscular dystrophy, chronic fatigue
  • SYNONYM: None
  • CLASS: Food supplement
  • HALF-LIFE: N/A
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

None known

CoQ-10 was first identified in 1957. It is widely used in Japan where millions of Japanese patients receive CoQ-10 as part of their treatment for congestive heart failure.

Our database has 0 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe



Page last updated 01/07/2014

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric